bradykinin antagonistTherapeutic Peptides
Icatibant (Firazyr)
A synthetic decapeptide bradykinin B2 receptor antagonist. FDA-approved for acute attacks of hereditary angioedema. Selective competitive antagonist that blocks vasodilation and edema caused by bradykinin.
angioedemabradykinin-antagonistanti-inflammatoryFDA-approved
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A synthetic decapeptide bradykinin B2 receptor antagonist. FDA-approved for acute attacks of hereditary angioedema. Selective competitive antagonist that blocks vasodilation and edema caused by bradyk…